Adage Capital Management, L.P. - Significant Ownership

Signature - Title
Phillip Gross - Managing Member of Reporting Partner
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Adage Capital Management, L.P..

Significant Ownership of Adage Capital Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MNPR Monopar Therapeutics Common Stock, par value $0.001 per share 9.86% $17.7M 599K Adage Capital Management, L.P. Dec 31, 2024
ALGS Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 9.38% $3.51M 325K Adage Capital Management, L.P. Dec 31, 2024
PRQR ProQR Therapeutics N.V. Ordinary Shares nominal value Euro 0.04 per share 9.3% $17.8M 9.6M Adage Capital Management, L.P. Dec 31, 2024
ACRS Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share 9% $19.2M 9.63M Adage Capital Management, L.P. Dec 31, 2024
EYPT EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.42% $42.1M 5.75M Adage Capital Management, L.P. Dec 31, 2024
DYNX Dynamix Corp Class A Ordinary Shares, par value $0.0001 per share 8.13% $13.3M 1.35M Adage Capital Management, L.P. Dec 31, 2024
STR Sitio Royalties Corp. Class A Common Stock, par value $0.0001 per share 7.9% $123M 6.26M Adage Capital Management, L.P. Dec 31, 2024
URGN UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share 6.94% $31.7M 2.93M Adage Capital Management, L.P. Dec 31, 2024
ZVRA Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.84% $28.9M 3.65M Adage Capital Management, L.P. Dec 31, 2024
LXEO Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.68% $5.88M 2.21M Adage Capital Management, L.P. Dec 31, 2024
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 6.56% $9.16M 2.25M Adage Capital Management, L.P. Dec 31, 2024
FULC Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share 5.56% $11.5M 3M Adage Capital Management, L.P. Dec 31, 2024
JANX Janux Therapeutics, Inc. Common Stock, $0.001 par value per share 5.31% $97.4M 3.06M Adage Capital Management, L.P. Dec 31, 2024
SDRL Seadrill Ltd Common Shares, par value $0.01 per share 5.31% $82.1M 3.43M Adage Capital Management, L.P. Dec 31, 2024
KPTI Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share 5.18% $3.93M 6.55M Adage Capital Management, L.P. Dec 31, 2024
ENGN enGene Holdings Inc. Common Shares, with no par value per share 3% $8.09M 1.53M Adage Capital Management, L.P. Dec 31, 2024
IMUX Immunic, Inc. Common stock, par value $0.0001 per share 1.55% $1.57M 1.4M Adage Capital Management, L.P. Dec 31, 2024

Schedules 13D/G Reported by Adage Capital Management, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.